When your child feels sick, finding the right medicine can be a challenge. Ondansetron is often used to help kids with nausea, but parents worry about potential side effects, especially when it comes to heart health. A recent review looked at how this medication affects healthy children’s heart rhythms. It found that while there is a small increase in certain heart measurements after taking ondansetron, the chances of serious heart problems are extremely low. Specifically, only about 2.5% of kids showed significant changes, and none experienced any serious heart rhythm issues. This means that ondansetron can be a safe option for treating nausea in children. However, it’s important for parents to discuss any concerns with their healthcare provider, especially if their child has existing heart conditions. As always, staying informed and communicating with your doctor is key to ensuring your child's health and safety.
Is Ondansetron Safe for Kids? New Insights on Heart Health
Plain Language Summary
What this means for you:
Ondansetron is generally safe for kids, with minimal heart risks, making it a trusted choice for nausea relief. What this means for you:
Ondansetron is generally safe for kids, with minimal heart risks, making it a trusted choice for nausea relief. View Original Abstract ↓
OBJECTIVE: The aim of this study was to describe electrocardiographic changes in healthy pediatric patients receiving low-dose ondansetron and to determine whether these changes are associated with the occurrence of cardiac dysrhythmias.
DATA SOURCE: The search was conducted in PubMed, EMBASE, LILACS, SciELO, and the Cochrane databases, selecting articles published until September 2024. The primary outcome was the mean change in the corrected QT interval (QTc) interval. The mean variation of the Tp-e interval and the incidence of significant QTc prolongation were assessed as secondary outcomes.
DATA SYNTHESIS: Four studies were included in this review, including 231 healthy pediatric patients who received ondansetron (IV or oral). Most were male, aged 0.6-18 years. The mean IV ondansetron dose ranged from 0.1 to 0.2 mg/kg, while the mean oral dose was 0.18 mg/kg, with a maximum dose of 8 mg. The mean change in the QTc interval was 4.7 ms (95% confidence interval [CI] 1.48.1), and in the Tp-e interval was 7.7 ms (95%CI 2.0-13.5). The risk of a significant QTc prolongation was 2.5% (95%CI -0.009-0.059). No dysrhythmia was observed in the studies.
CONCLUSIONS: There was a statistically significant increase in QTc and Tp-e intervals following ondansetron administration in healthy pediatric patients. However, it is highly unlikely that these changes result in cardiac dysrhythmia, suggesting no relationship between low-dose ondansetron use and an increased risk of dysrhythmia in healthy pediatric patients.